A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 2534-2540

  Wang, Yongcheng ^a   Yao, Jie ^a,b   Meng, Haoye ^a   Yu, Zhiguo ^b   Wang, Zhigang ^b   Yuan, Xueling ^a   Chen, Hong ^c   Wang, Aiyuan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Department of Oncology PLA No 161 Center Hospital   (China)

^c KUNMING GENERAL HOSPITAL   (China)

Author keywords

Cancer stem cell; Hypoxia inducible factor 2 ; Long non coding RNA; Osteosarcoma

Indexed keywords

BETA ACTIN; CD133 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA PROMOTER UPSTREAM TRANSCRIPT; LONG UNTRANSLATED RNA; MESSENGER RNA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; SMALL INTERFERING RNA;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; OSTEOSARCOMA; OSTEOSARCOMA STEM CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCHOOL CHILD; YOUNG ADULT; BONE TUMOR; CANCER STAGING; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 84921344556     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3024     Document Type: Article

References (26)

1. Stiller CA: International patterns of cancer incidence in adolescents. Cancer Treat Rev 33: 631-645, 2007.
2. Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC and Gebhardt MC: Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res 429: 286-291, 2004
3. Harting MT, Blakely ML, Jaffe N, et al: Long-term survival after aggressive resection of pulmonary metastases among children and 4 adolescents with osteosarcoma. J Pediatr Surg 41: 194-199, 2006.
4. Merlos-Suárez A, Barriga FM, Jung P, et al: The intestinal stem cell signature identifes colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8: 511-524, 2011.
5. Takahashi S, Kamiyama T, Tomaru U, et al: Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients. Oncol Rep 24: 1201-1212, 2010.
6. Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460-466, 2007.
7. Huarte M and Rinn JL: Large non-coding RNAs: missing links in cancer? Hum Mol Genet 19: R152-R161, 2010.
8. Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31: 4577-4587, 2012.
9. Tsai MC, Spitale RC and Chang HY: Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71: 3-7, 2011.
10. Guttman M, Donaghey J, Carey BW, et al: lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477: 295-300, 2011.
11. Preker P, Nielsen J, Kammler S, et al: RNA exosome depletion reveals transcription upstream of active human promoters. Science 322: 1851-1854, 2008.
12. Jacquier A: The complex eukaryotic transcriptome: unexpected pervasive transcription and novel small RNAs. Nat Rev Genet 10: 833-844, 2009
13. Preker P, Almvig K, Christensen MS, et al: PROMoter uPstream Transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Res 39: 7179-7193, 2011.
14. Taft RJ, Kaplan CD, Simons C and Mattick JS: Evolution, biogenesis and function of promoter-associated RNAs. Cell Cycle 8: 2332-2338, 2009.
15. Ijichi N, Ikeda K, Fujita M, et al: EPAS1, a dexamethasone-inducible gene in osteoblasts, inhibits osteoblastic differentiation. Open Bone J 1: 28-37, 2009.
16. Li Z, Bao S, Wu Q, et al: Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513, 2009.
17. Gordan JD, Bertout JA, Hu CJ, Diehl JA and Simon MC: HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335-347, 2007.
18. Covello KL, Kehler J, Yu H, et al: HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20: 557-570, 2006.
19. Yang X, Song JH, Cheng YL, et al: Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63; 881-890, 2014.
20. Siclari VA and Qin L: Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res 5: 78, 2010.
21. + cancer stem cells in human solid tumours. PLoS One 3: e3469, 2008.
22. Williams GT, Mourtada-Maarabouni M and Farzaneh F: A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes. Biochem Soc Trans 39: 482-486, 2011.
23. Knowles HJ, Schaefer KL, Dirksen U and Athanasou NA: Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor. BMC Cancer 10: 372, 2010.
24. Acker T, Diez-Juan A, Aragones J, et al: Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell 8: 131-141, 2005.
25. Yu L and Hales CA: Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice. BMC Cancer 11: 331, 2011.
26. Biswas S, Charlesworth PJ, Turner GD, et al: CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. Carcinogenesis 33: 1717-1725, 2012.